1,485,600 of its own shares, corresponding to 1.27% of Panoro's share capital.

the contract has a duration of approximately 140 days.

website: https://carasent.com/investors/relisting-to-nasdaq-stockholm-2024/.

of the Company’s core trade lanes. Shipments under the contract will commence January 1, 2025.

convertible bonds as issued to Atlas Special Opportunities, LLC ("Atlas") under ...

vessels of approximately US$1,700 per day. The Company's one vessel trading on a fixed time charter earned approximately US$30,000 per day, gross. The Company's eleven vessels trading on index-linked ...

Wound & Skin Care AS, and a Swedish subsidiary Water Innovation AB (WIAB). To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or ...

AS (www.norne.no/nbx). The subscription period for the Rights Issue ends on 9 December 2024 at 16:30 (CET).

Growth Oslo and publication of Information Document. As set out in the Information Document, a limited number of the Company's shares were not admitted to trading at that time, as the relevant ...

(the ”Board”) to call for an extraordinary general meeting to be held on 19 December 2024 (the “EGM”), and (vi) an update on its ongoing strategic review.

certain loans from Navamedic ASA ("Navamedic") to Observe Medical. Navamedic currently holds 4,222,727 shares in Observe Medical, equal to approx. To subscribe to Press releases from this issuer, ...

subsidiary of Norconsult ASA, and Longva Arkitekter AS.